Research programme: anti-Ebola monoclonal antibodies - PlantForm Corporation

Drug Profile

Research programme: anti-Ebola monoclonal antibodies - PlantForm Corporation

Alternative Names: Antibodies for Ebola virus (Sudan) - PlantForm Corporation

Latest Information Update: 23 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PlantForm Corporation
  • Developer PlantForm Corporation; United States Army Medical Research Institute of Infectious Diseases
  • Class Monoclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Ebola virus infections

Most Recent Events

  • 13 Dec 2016 The University of New Mexico partners with PlantForm Corporation on Filoviridae glycoprotein project
  • 11 Jun 2015 Preclinical trials in Ebola virus infections in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top